Literature DB >> 2568544

Treatment of meningioma with octreotide.

M W Rünzi, C Jaspers, R Windeck, G Benker, M Mehdorn, V Reinhardt, D Reinwein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2568544     DOI： 10.1016/s0140-6736(89)90400-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

Authors:  Thomas Kaley; Igor Barani; Marc Chamberlain; Michael McDermott; Katherine Panageas; Jeffrey Raizer; Leland Rogers; David Schiff; Michael Vogelbaum; Damien Weber; Patrick Wen
Journal:  Neuro Oncol       Date:  2014-02-04       Impact factor: 12.300

2.  Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.

Authors:  Derek R Johnson; David W Kimmel; Patrick A Burch; Terrence L Cascino; Caterina Giannini; Wenting Wu; Jan C Buckner
Journal:  Neuro Oncol       Date:  2011-05       Impact factor: 12.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.